Literature DB >> 29525829

Somatic symptoms in women with dysmenorrhea and noncyclic pelvic pain.

Rebecca M Zuckerman1, Rebecca L Silton2, Frank F Tu1,3, Joshua S Eng4, Kevin M Hellman1,3.   

Abstract

Somatic symptoms are a robust, transdiagnostic risk factor for pain conditions. However, the extent to which somatic symptoms contribute to the manifestation of the women's pain syndromes, such as dysmenorrhea and noncyclic pelvic pain (NCPP), is unclear due to high rates of co-occurrence. Therefore, the present study investigated the primary hypothesis that somatic symptoms would be elevated in NCPP and distinctly influence the relationship between dysmenorrhea and co-occurring NCPP. A secondary analysis was performed on cross-sectional questionnaire data from 1012 nonpregnant reproductive-aged women. Eligible analyzed participants (n = 834) were categorized into four groups: healthy, dysmenorrhea, NCPP, and NCPP with co-occurring dysmenorrhea (NCPP+dysmenorrhea). A parallel mediation analysis was run to evaluate the primary hypothesis that somatic symptoms are the primary factor associated with increased NCPP accounting for dysmenorrhea. The NCPP+dysmenorrhea group had higher somatic, anxiety, and depression symptom T-scores (respectively 61, 61, 60) compared to the healthy controls (46, 51, 51; p's < .001) and the dysmenorrhea group (50, 53, 54; p's < .001). The pain and psychological symptoms were significantly correlated across the entire sample (r's = .29, - .64, p's < .01). Results from parallel mediation analysis showed that somatic symptoms were distinctly associated with NCPP+dysmenorrhea. Women with NCPP+dysmenorrhea have increased psychological and somatic symptoms compared to women with dysmenorrhea alone. Given that NCPP often co-occurs with dysmenorrhea, failure to account for comorbidity in previous studies has likely led to an overestimation of psychological symptoms in dysmenorrhea. Future studies should evaluate whether somatic sensitivity is a modifiable risk factor for NCPP.

Entities:  

Keywords:  Comorbidity; Dysmenorrhea; Noncyclic pelvic pain; Somatic symptoms

Mesh:

Year:  2018        PMID: 29525829      PMCID: PMC6126970          DOI: 10.1007/s00737-018-0823-4

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  52 in total

Review 1.  Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials.

Authors:  K Kroenke; R Swindle
Journal:  Psychother Psychosom       Date:  2000 Jul-Aug       Impact factor: 17.659

Review 2.  A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain.

Authors:  Tamar Pincus; A Kim Burton; Steve Vogel; Andy P Field
Journal:  Spine (Phila Pa 1976)       Date:  2002-03-01       Impact factor: 3.468

3.  The prevalence of menstrual pain and associated risk factors among Iranian women.

Authors:  Mahkam Tavallaee; Michel R Joffres; Stephen J Corber; Mana Bayanzadeh; Mahnaz Mahmoudi Rad
Journal:  J Obstet Gynaecol Res       Date:  2011-01-05       Impact factor: 1.730

4.  The development of a menstrual distress questionnaire.

Authors:  R H Moos
Journal:  Psychosom Med       Date:  1968 Nov-Dec       Impact factor: 4.312

5.  Pain perception in women with dysmenorrhea.

Authors:  M Granot; D Yarnitsky; J Itskovitz-Eldor; Y Granovsky; E Peer; E Z Zimmer
Journal:  Obstet Gynecol       Date:  2001-09       Impact factor: 7.661

6.  Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.

Authors:  F Creed; J Ratcliffe; L Fernandez; B Tomenson; S Palmer; C Rigby; E Guthrie; N Read; D Thompson
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

7.  Increased symptoms in female IBS patients with dysmenorrhea and PMS.

Authors:  Gaylene Altman; Kevin C Cain; Sandra Motzer; Monica Jarrett; Robert Burr; Margaret Heitkemper
Journal:  Gastroenterol Nurs       Date:  2006 Jan-Feb       Impact factor: 0.978

8.  Bleeding out the quality-adjusted life years: evaluating the burden of primary dysmenorrhea using time trade-off and willingness-to-pay methods.

Authors:  Fanni Rencz; Márta Péntek; Peep F M Stalmeier; Valentin Brodszky; Gábor Ruzsa; Edina Gradvohl; Petra Baji; László Gulácsi
Journal:  Pain       Date:  2017-11       Impact factor: 6.961

9.  Psychological factors associated with development of TMD: the OPPERA prospective cohort study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Luda Diatchenko; Ronald Dubner; Eric Bair; Cristina Baraian; Nicole Mack; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

10.  Somatoform disorder as a predictor of interstitial cystitis/bladder pain syndrome: Evidence from a nested case-control study and a retrospective cohort study.

Authors:  I-Chun Chen; Ming-Huei Lee; Hsuan-Hung Lin; Shang-Liang Wu; Kun-Min Chang; Hsiu-Ying Lin
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

View more
  3 in total

1.  Perceived Ineffectiveness of Pharmacological Treatments for Dysmenorrhea.

Authors:  Chen X Chen; Janet S Carpenter; Michelle LaPradd; Susan Ofner; J Dennis Fortenberry
Journal:  J Womens Health (Larchmt)       Date:  2020-10-07       Impact factor: 3.017

2.  Dysmenorrhea subtypes exhibit differential quantitative sensory assessment profiles.

Authors:  Kevin M Hellman; Genevieve E Roth; Katlyn E Dillane; Ellen F Garrison; Folabomi A Oladosu; Daniel J Clauw; Frank F Tu
Journal:  Pain       Date:  2020-06       Impact factor: 7.926

3.  Persistent autonomic dysfunction and bladder sensitivity in primary dysmenorrhea.

Authors:  Folabomi A Oladosu; Kevin M Hellman; Paula J Ham; Laura E Kochlefl; Avisek Datta; Ellen F Garrison; Nicole D Steiner; Genevieve E Roth; Frank F Tu
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.